January 28, 2014 In Herbal Research

Systematic review & meta-analysis

Traditional Chinese herbal decoctions for the treatment of gout: equal to Western medicine in efficacy, superior in controlling adverse drug effects (Abstract, Free full text)

Clinical trials

Juglans regia (common walnut) leaves, aqueous extract: significantly decreased total cholesterol and triglyceride levels in patients with type 2 diabetes (Abstract)

Withania somnifera (ashwagandha): a prospective trial on chemotherapy-induced fatigue and quality of life in breast cancer patients (Abstract)

Read more for preclinical research and other updates:


Fritillaria spp.: molecular phylogeny, chemotaxonomy, and resource utilization (Abstract)

Pharmacological tools for the study of traditional Chinese medicine (Abstract)

Preclinical research

Albizia lebbeck (lebbeck tree) root extract: wound-healing potential (Abstract)

Althaea officinalis (marshmallow) extract: neuroprotective effect in a Parkinson’s disease model in mice (Abstract)

Betula sp. (birch) bark extract: wound-healing potential (Abstract, Free full text)

Echinacea purpurea, E. pallida: seasonal variation (Abstract)

Lythrum salicaria (purple loosestrife): cytotoxic constituents of the plant (Abstract)

Nardostachys jatamansi (spikenard) rhizome: anticholinesterase activity (Abstract, Free full text)

Nelumbo nucifera (lotus) flower: anticholinesterase activity (Abstract, Free full text)

Niprisan®, also Nicosan or Hemoxin, a herbal-based orphan drug*: effects on CYP3A4 activity (Abstract)

Panax notoginseng (tienchi, sanqi): stroke recovery (Abstract, Free full text)

Phyllanthus emblica (amla) whole fruit: anticholinesterase activity (Abstract, Free full text)

Trigonella foenum-graecum (fenugreek) leaf and seed: antioxidant, oxidative DNA damage-protective, and antimicrobial activities (Abstract)

* An “orphan drug” in the US (see Title 21 CFR, Part 316) is a drug intended for use in a rare disease or condition. Niprisan®, originally developed by a Nigerian firm, appears to be approved in the US, at least until March 21, 2014 (based on this document; scroll for #1597), for the treatment of sickle-cell anemia.

Individual constituents

A new β-carboline isolated from the seeds of Griffonia simplicifolia (Abstract)


Nigella sativa (black cumin) (Letter, free full text)

environmental resource management | Novel uses

Trigonella foenum-graecum (fenugreek) leaf: high content of phenolics (Abstract)

Vitis vinifera (grape) stem: antioxidant potential of winemaking by-products (Abstract)


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s